A woman with synchronous cervical, vaginal and laryngeal squamous cell carcinomas and positive human papillomavirus type 16; case presentation with literature review

Journal of B.U.ON.

Volumn 13, Issue 1, 2008, Pages 109-112

  Georgieva, S ^a   Iordanov, Victor ^b  

^a Queen Giovanna Hospital   (Bulgaria)

^b National Oncology Center Bulgaria   (Bulgaria)

Author keywords

Anorectal cancer; Cervical cancer; Head and neck tumors; Human papillomavirus

Indexed keywords

CISPLATIN; IRIDIUM 192; VIRUS ANTIBODY;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; LARYNGEAL BIOPSY; LARYNGOSCOPY; LARYNX CARCINOMA; RADIATION DOSE; RADICAL HYSTERECTOMY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VAGINA CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; LARYNGEAL NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS;

EID: 41549140837     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
2. Villa LL. Biology of genital human papillomaviruses. Int J Gynecol Obstet 2006; 94 (Suppl 1): S3-S7.
3. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005; 32 (Suppl): S59-S66.
4. El Serag HB, Hepworth EJ, Lee P, Sonnenberg A. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol 2001; 96:2013-2018.
5. Wen S, Tsuji T, Li X. Detection and analysis of human papillomavirus 16 and 18 homologous DNA sequences in oral lesions. Anticancer Res 1997; 17: 307-311.
6. Herrero R. Human papillomavirus and cancer of the upper aerodigestive tract. Natl Cancer Inst Monographs, chapter 7, 2003; 31: 47-51.
7. Munger K. The role of human papilloma viruses in human cancers. Front Biosci 2002; 7: d641-d649.
8. Mitsuishi T, Kawana S, Kato T, Kawashima M. Human papillomavirus infection in actinic keratosis and Bowen's disease: comparative study with expression of cell-cycle regulatory proteins p21 Waf1/Cip1, p53, PCNA, Ki-67, and Bcl-2 in positive and negative lesions. Human Pathol 2003; 34: 886-892.
9. de Oliveira DE. DNA viruses inhuman cancer: An integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett 2007; 247: 182-196.
10. Dahlstrom RK, Adler-Storthz K, Etzet JC et al. Human papillomavirus type 11, 16 infection and squarnous cell carcinoma of the head and neck in never smokers. Clin Cancer Res 2003; 9: 2620-2626.
11. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
12. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350.
13. Bosch XF, Qiao Y-L, Castellsaque X. The epidemiology of human papillomavirus; infection and its association with cervical cancer. Intern J Gynecol Obst 2006; 94 (Suppl 1): 8-21.
14. Frisch M, Glimelins B, Van den Brule AJC et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997;337: 1350-1358.
15. Sugiyama M, Bhawal UK, Kawamura M et al. Human papillomavirus 16 in oral squamous cell carcinoma: Clinical correlates and 5-year survival. Br J Oral Maxillofac Surg 2007; 45: 116-122.
16. Leggatt GR, Frazer IH. HPV vaccines: the beginning of the end for cervical cancer. Cur Opin Immunol 2007; 19: 232-238.
17. Modis Y, Teus BL, Harrison SC. Atomic model of the papilloma virus capsid. EMBO J 2002; 21: 4754-4762.